HLB테라퓨틱스: directors' dealings · South Korea · DART (FSS)

Explore the full management transaction log of HLB테라퓨틱스, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, HLB테라퓨틱스 has recorded 11 insider filings. Market capitalisation: €264.9bn. The latest transaction was disclosed on 11 March 2026 (Purchase). Among the most active insiders: HLB. Every trade is accessible without an account.